Last edition
News about "NHS-Galleri trial"
GRAIL Reports Topline Results from NHS-Galleri Trial of Multi-Cancer Early Detection Test
Results from the NHS-Galleri trial show that annual multi-cancer screening with the Galleri test reduced Stage IV diagnoses and significantly increased early cancer detection across England’s NHS population.
NHS-Galleri Trial | 20/02/2026 | By News Bureau | 262
Grail Submits Final PMA Module to FDA for Galleri Multi-Cancer Early Detection Test
Grail files the final Premarket Approval module with the FDA for its Breakthrough Device-designated Galleri test, supported by data from over 25,000 participants in PATHFINDER 2 and the NHS-Galleri trial.
NHS-Galleri Trial | 30/01/2026 | By News Bureau | 399
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy